CytRx Corporation’s Executive Vice President and Chief Medical Officer Dr. Daniel Levitt to Present Oncology Grand Rounds at Louisiana State University School of Medicine

Published: Jun 20, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced that Executive Vice President and Chief Medical Officer Daniel Levitt, M.D., Ph.D., will give the Grand Rounds presentation today to the prestigious Department of Hematology and Oncology at LSU Medical School in New Orleans. The presentation, “The Diversity of Albumin-Linked Cancer Drugs,” will focus on advancements in CytRx’s program with aldoxorubicin, an improved version of the widely used chemotherapeutic doxorubicin.

Help employers find you! Check out all the jobs and post your resume.

Back to news